Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Launches collaborative centre for translational research in head and neck cancer
Max Healthcare Institute has reported total income of Rs. 1380.99 crores during the period ended December 31, 2023
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Subscribe To Our Newsletter & Stay Updated
